跳至主要内容
临床试验/NCT03062488
NCT03062488已完成早期 1 期

Emergence Agitation and Pain Scores in Pediatric Patients Following Sevoflurane Anesthesia When Comparing Single-modal Versus Multi-modal Analgesia for Routine Ear-nose-throat (ENT) Surgery, a Multi-center Double-blinded Study

Nemours Children's Clinic1 个研究点 分布在 1 个国家目标入组 143 人开始时间: 2017年10月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
143
试验地点
1
主要终点
Emergence Agitation (EA) as Measured by Standardized PAED Scale

研究概览

简要总结

The purpose of this study is to compare the incidence of EA in pediatric patients undergoing minor ENT surgery under Sevoflurane and compare opioid-only based intra-operative analgesia to multi-modal analgesia consisting of opioid and IV acetaminophen or PO acetaminophen regimen using a validated and standardized EA measurement tool, the Pediatric Anesthesia Emergence Delirium (PAED) scale. The post operative pain scores will be measured in all patients by post-op recovery staff using FLACC Score/Wong-Baker FACES (patients 24 months up to 7 years of age) or Numeric Pain Score for patients 7 years of age. The pre-operative, surgery, anesthesia and post-operative staff will be all blinded.

详细描述

Place of Study:

Nemours Children's Hospital, Orlando, Florida (Primary Site) Wolfson Children's Hospital, Jacksonville, Florida (Nemours Jacksonville Satellite Site)

Study Design:

Prospective Randomized Study Total Number of Patients: 150

Methods and Materials: 150 patients will be randomly divided into three groups of 50 patients. Each group will receive sevoflurane induction and maintenance of anesthesia. Sevoflurane, currently the most commonly used agent for inhalational induction, will be used for induction of anesthesia, as it is less irritating to the tracheobronchial tree than other volatile anesthetic agents and is considered the standard for pediatric induction anesthesia. These three groups, (study arms), are identified as follows:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

all patients will receive a de-identified PO syrup. The syrup will be prepared by the pharmacy and will contain acetaminophen (15 mg/kg) for the PO acetaminophen group and placebo flavored syrup for the other two groups. This approach will maintain blindness of the peri-operative staff, and patients/parents., all children will receive fentanyl 2 mcg/Kg IV. Intra-op anesthesia team will be blinded to the use of non-opioid IV analgesia and will administer a pharmacy prepared de-identified infusion following intubation that will consist of saline placebo for control groups and IV acetaminophen (15 mg/kg) for the IV acetaminophen group. ,

:A blinded PACU nurse will record degree of agitation using the PAED scale on admission to the PACU

入排标准

年龄范围
24 Months 至 7 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Patients who are 24 months through 7 years of age
  • Patients who weigh <50 kg
  • Patients who are able to take PO medications
  • Patients who are ASA Classification I and II
  • Patients who are found to be a candidate after clinical review of detailed History and Physical Exam, review of Polysomnogram or Pediatric Sleep Questionnaire
  • Patients who are scheduled for routine adenoidectomy or tonsillectomy with or without adenoidectomy not in conjunction with another invasive or diagnostic procedure
  • Patients who meet clinical indications for surgery
  • Family and patient must be proficient in English to understand consent, post-operative instructions, and facilitate the assessment after emergence of anesthesia

排除标准

  • Children with a history of developmental delay or psychological disorders that may be at higher risk for EA as determined by study physician after review of history and problem list in EMR
  • Patients with previous hypersensitivity to oral or intravenous acetaminophen, fentanyl or any of its components or ingredients in placebo,
  • Patients with severe hepatic impairment or severe active hepatic disease
  • Patients with previous history of Malignant Hyperthermia or susceptibility to volatile anesthetics agents like sevoflurane
  • Any patient who weighs >50 Kg.
  • Any patient that requires premedication. Versed may contribute to an increase in EA. Premedication is reserved when parental presence is not feasible or for very anxious children.
  • Patients unable to take PO (acetaminophen or placebo) will be excluded from the study.
  • Children with severe symptomatic sleep apnea that require post-operative hospitalization.
  • Severe symptomatic sleep apnea is defined as a- patients who has a pre-operative polysomnogram and a calculated Apnea-Hypoxia Index greater than 10 b- patients with high scoring in Pediatric Sleep Questionnaire (PSQ)
  • Patients with severe symptoms and findings in physical exam that require post-operative hospital admission.
  • Patients and/or families not proficient in English
  • Participant is currently participating or has within the previous 30 days, participated in another clinical trial/research study

研究组 & 干预措施

opioid plus IV acetaminophen

Active Comparator

2 mcg/Kg of fentanyl plus 15mg/Kg of IV acetaminophen

干预措施: Fentanyl (Drug)

opioid plus IV acetaminophen

Active Comparator

2 mcg/Kg of fentanyl plus 15mg/Kg of IV acetaminophen

干预措施: IV acetaminophen (Drug)

opioid only

Active Comparator

2 mcg/Kg of fentanyl

干预措施: Fentanyl (Drug)

opioid plus PO analgesic

Active Comparator

2 mcg/Kg of fentanyl plus PO acetaminophen 15 mg/Kg

干预措施: Fentanyl (Drug)

opioid plus PO analgesic

Active Comparator

2 mcg/Kg of fentanyl plus PO acetaminophen 15 mg/Kg

干预措施: PO acetaminophen (Drug)

结局指标

主要结局

Emergence Agitation (EA) as Measured by Standardized PAED Scale

时间窗: first 60 minutes of recovery post anesthesia

Post Anesthesia Emergence Delirium (PAED) Scale 0 - 20. EA defined as a score equal or greater than 12

次要结局

  • Post Operative Pain(Average in first 60 minutes of recovery post anesthesia)
  • Post Operative Fentanyl Consumption(first 60 minutes in the PACU)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验